血清中胆和摄入量与儿童喘之间的相互作用:一个横截面研究
Jianwei Cao1, Meiling Liu2, Zhongquan Wang1
1Kangyi VIP Clinic, Zhongshan People's Hospital, Zhongshan, China.
International archives of allergy and immunology
|August 20, 2023
概括
血清中高氨酸和低摄入量增加了儿童喘风险. 结合起来,它们会增加风险,这表明禁烟和富含的饮食可能有助于预防儿童喘.
科学领域:
- 环境健康 环境健康
- 营养科学 营养科学
- 儿科呼吸系统医学 儿科呼吸系统医学
背景情况:
- 儿童喘是一个重大的公共卫生问题.
- 血清丁胺 (烟草烟雾暴露的标志物) 和摄入量独立地与喘有关.
- 这些因素对儿童喘风险的相互作用影响需要进一步研究.
研究的目的:
- 评估与儿童喘有关的血清丁水平和食摄入量之间的相互作用.
- 为了确定高丁胺和低的联合暴露是否会改变喘风险.
- 根据这些相互作用,确定潜在的预防策略.
主要方法:
- 从国家健康和营养检查调查 (2005-2018) 中对14159名儿童进行横截面研究.
- 血清胆固醇和摄入量被根据四分位数分为高和低水平.
- 进行了加权后勤回归和相互作用分析,根据性别,BMI和家族史进行了分层分析.
主要成果:
- 血清中高丁胺水平与喘风险增加有关 (OR=1.25).
- 低摄入量也与更高的喘患病率有关 (OR=1.21).
- 观察到一种显著的相互作用:高丁胺和低摄入量显示出喘风险最高 (OR=1.35),特别是在男性和超重儿童中.
结论:
- 血清丁和摄入量在确定儿童喘风险方面有显著的相互作用.
- 这些发现支持公共卫生干预措施,如禁烟和对富含的食物的饮食建议.
- 针对环境烟雾暴露和营养状况的向可能对预防喘至关重要.
更多相关视频
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.2K
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.1K
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342
Antiasthma Drugs: Leukotriene Modifiers
355
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
355
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
333
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
333
Antiasthma Drugs: Methylxanthines
269
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
269
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
